Brianna Serbus, MD
Family Medicine · Fort Wayne, INNPI 1174885040
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $172,439 of the $174,251 with a category attached, or 99.0%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 80.1% of it on its own, with 17 other manufacturers making up the rest. Among family medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 172 payments — averaging $1013.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$140K
- Shire North American Group Inc$33K
- Lilly USA, LLC$500
- AbbVie$189
- Novo Nordisk$85
- GSK$83
- plus $465 from 12 others
What the payments were for
- Consulting fees$172,43999%
- Travel & lodging$4790%
- Food & beverage$1,3321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 68 | $139,544 |
| Shire North American Group Inc | 25 | $33,384 |
| Lilly USA, LLC | 25 | $500 |
| AbbVie(2 entities) | 12 | $189 |
| Novo Nordisk | 6 | $85 |
| GSK | 6 | $83 |
| Axsome Therapeutics, Inc. | 5 | $81 |
| Astellas Pharma US Inc | 3 | $76 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $53 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| AstraZeneca | 3 | $38 |
| Pfizer | 3 | $38 |
| Boehringer Ingelheim | 3 | $36 |
| Corium, LLC | 3 | $33 |
| Novartis | 1 | $23 |
| Exact Sciences | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEPBOUND$116
How this compares
$174,251 in reported general payments places this provider in the 95th percentile of 2,709 family medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 55 | $66,454 |
| JardianceEmpagliflozin | 38 | $60,185 |
| TrulicityDulaglutide | 27 | $45,605 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 39 | $44,292 |
| EliquisApixaban | 22 | $33,411 |
| MounjaroTirzepatide | 20 | $25,063 |
| JanuviaSitagliptin Phosphate | 17 | $14,721 |
| HorizantGabapentin Enacarbil | 18 | $14,179 |
| VascepaIcosapent Ethyl | 12 | $10,666 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $6,094 |
| SymbicortBudesonide/Formoterol Fumarate | 17 | $6,007 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 168 | $4,102 |
| Dexlansoprazole DrDexlansoprazole | 26 | $3,468 |
| Levothyroxine Sodium | 329 | $3,074 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 30 | $3,074 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $500 | $70,66747 claims |
| Novo NordiskOzempic | $85 | $66,45455 claims |
| Boehringer IngelheimJardiance | $36 | $60,18538 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $83 | $50,38552 claims |
| PfizerEliquis | $38 | $33,41122 claims |
| AstraZenecaSymbicort | $38 | $6,00717 claims |
| AbbVieSynthroid | $189 | $1,90423 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Fort Wayne
- Thomas KintanarFort Wayne$185K
- Brian AdamsFort Wayne$173K
- Charles CoatsFort Wayne$38K
- Beulah PenumudiFort Wayne$38K
- Nehal SinghFort Wayne$20K
- Peter JakackiFort Wayne$19K
- Sarah TurnerFort Wayne$17K
- Hector PerezFort Wayne$16K
- Richard TannerIndianapolis$1.6M
- James AndryBloomington$715K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.